| Sanofi-Aventis (Suisse) SA - Suliqua 100/50, solution injectable |
| 66283 | | 01 | | Suliqua 100/50 | | solution injectable | | A10AE54 | | Insulin Glargine and Lixisenatide | | 05.10.2017 | | |
|
| Composition |
| insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 U., lixisenatidum 50 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Insulin Glargine | 3.64 mg/ml correspond Insulin Glargine 100 U/ml | | Lixisenatidum | 50 µg/ml |
| | BAG: Active Agent | Dose |
|---|
| Insulin Glargine | 100 U | | Lixisenatidum | 50 mcg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Glycerol | | | | Metacresol | 2.7 mg/ml | conserv. | | Methionine | | | | Zinc Chlorideate | | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 3 | 82.73 | 106.40 | B | SL | Yes |
|
